GENE:NFE2L2
GeneInfo:
GeneAttribute | GeneDescription |
---|---|
GeneSymbol | NFE2L2 |
FullNmae | NFE2 like bZIP transcription factor 2 |
LocusType | gene with protein product |
Status | Approved |
HGNC_id | HGNC:7782 |
EnsembleID | ENSG00000116044 |
Uniprot | Q16236 |
Protein Structure:
Gene Description in Publicaton:
GeneSymbol | CellDeathType | PMID | Description | GeneType |
---|---|---|---|---|
NFE2L2 | mitotic_cd | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
NFE2L2 | ferroptosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
NFE2L2 | ferroptosis | 36341760 | The PCD-related genes contained the key regulatory genes of twelve PCD patterns which is mentioned above. Genes were collected from GSEA gene sets, KEGG, review articles, and manual collation [10]. The ultimate gene list was the concatenation regulatory genes of twelve PCD patterns. | regulator signature |
NFE2L2 | cuproptosis | 36213577 | We created a prognostic profile consisting of nineteen cuproptosis-related genes (NFE2L2, LIPT1, LIPT2, DLD, etc.) and their connected targets. | retulator signature |
NFE2L2 | cuproptosis | 38200445 | In this study, four cuproptosis genes (i.e., NFE2L2, PDHA1, PDHB, and DLD) were found to have different roles in cuproptosis. | regulator |
NFE2L2 | cuproptosis | 38495196 | Cuproptosis-related genes were manually curated, and differentially expressed cuproptosis-related genes (DECuGs) were identified.Then, the 16 DECuGs were obtained by the intersection of the 5018 DEGs and 63 cuproptosis-related genes. | 63 cuproptosis-related genes |
NFE2L2 | cuproptosis | 37983626 | NFE2L2, NLRP3, GLS, LIPT1, and MTF1 were identified as potential cuproptosis predictors, thus shedding new light on ischemic stroke pathogenesis and heterogeneity. | predictior |
NFE2L2 | cuproptosis | 37983626 | NFE2L2 (Nrf2) is an important transcription factor that regulates multiple biological pathways, including metal ion balance, heme/iron metabolism, and antioxidant activity. Nrf2 physiologically regulates oxidative stress and inflammation, has critical involvement in neuroprotection, and might be associated with cuproptosis. It stabilizes GPX4 activity and mitochondrial redox balance by controlling copper oxidation-related genes and glutathione regulatory genes. | regulator |
NFE2L2 | cuproptosis | 38348451 | Namely Nrf2, a transcription factor that regulates antioxidant response element (ARE)-mediated genes. NFE2L2 activation can influence cellular redox status. | CRGs in the cuproptosis pathway |
NFE2L2 | cuproptosis | 38200445 | These results pointed out that NFE2L2 is the most closely related cuproptosis gene that can predict the occurrence and development of PE, followed by PDHA1, PDHB, and DLD. GLS resulted as the least closely related to PE. | related cuproptosis gene |
NFE2L2 | cuproptosis | 36050740 | A list of the cuproptosis-related genes was obtained from cuproptosis-related studies [18,19,20,21,22]. | cuproptosis-related genes |
NFE2L2 | cuproptosis | 36195876 | We found that all the 18 cuproptosis-related genes have significant value for predicting the prognosis of LIHC patients. Among them, 13 genes are risk factors, including NFE2L2, NLRP3, ATP7A, LIPT1, LIPT2, DLD, DLAT, PDHA1, PDHB, MTF1, GLS, CDKN2A and DLST. And the others are favorable factors, including FDX1, ATP7B, SLC31A1, LIAS and DBT. | cuproptosis-related genes |
NFE2L2 | cuproptosis | 35964468 | Cuproptosis-related gene sets were obtained from a previous study [9] and combined with the Molecular Signature Database (MsigDB) v7.0 database (http://www.gsea-msigdb.org/gsea/msigdb/, GOBP_CELLULAR_COPPER_ION_HOMEOSTASIS, GOBP_CELLULAR_RESPONSE_TO_COPPER_ION). | Cuproptosis-related gene sets obtained from Molecular Signature Database (MsigDB) v7.18 database. |
NFE2L2 | cuproptosis | 36313717 | The details of ninety-six candidate cuproptosis-related genes involved in the copper homeostasis regulatory pathway, copper metabolism diseases, mitochondrial respiratory, and iron-sulfur cluster proteins were exhibited in聽Table S1. | Cuproptosis genes related mitochondrial respiration |
NFE2L2 | cuproptosis | 36818726 | NLRP3, NFE2L2, ATP7A, LIPT1, GLS and MTF1 may serve as predictors of cuproptosis and play an important role in the pathogenesis of immune infiltration in IS. | predictors of cuproptosis |
NFE2L2 | autosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
NFE2L2 | apoptosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
NFE2L2 | apoptosis | 36341760 | The PCD-related genes contained the key regulatory genes of twelve PCD patterns which is mentioned above. Genes were collected from GSEA gene sets, KEGG, review articles, and manual collation [10]. The ultimate gene list was the concatenation regulatory genes of twelve PCD patterns. | regulator signature |
Go Annotation:
GeneSymbol | Go id |
---|---|
NFE2L2 | GO:0000785,GO:0000976,GO:0000976,GO:0000978,GO:0000981,GO:0000981,GO:0001221,GO:0001228,GO:0002931,GO:0003677,GO:0003700,GO:0005515,GO:0005634,GO:0005634,GO:0005634,GO:0005654,GO:0005737,GO:0005794,GO:0005813,GO:0005829,GO:0005829,GO:0005886,GO:0006357,GO:0006357,GO:0006954,GO:0006979,GO:0010499,GO:0010628,GO:0010667,GO:0010976,GO:0016567,GO:0019904,GO:0030194,GO:0030968,GO:0031625,GO:0032993,GO:0034599,GO:0034599,GO:0034599,GO:0034599,GO:0036003,GO:0036499,GO:0036499,GO:0042149,GO:0043161,GO:0043536,GO:0043565,GO:0045088,GO:0045454,GO:0045766,GO:0045944,GO:0045944,GO:0045995,GO:0046223,GO:0046326,GO:0061419,GO:0061629,GO:0070301,GO:0070301,GO:0071280,GO:0071356,GO:0071466,GO:0071498,GO:0071499,GO:0090575,GO:0140467,GO:1900038,GO:1900407,GO:1902037,GO:1902176,GO:1903071,GO:1903788,GO:1904385,GO:1904753,GO:2000121,GO:2000352,GO:2000379 |
KEGG Annotation:
GeneSymbol | GeneID | Pathway | Pathway Name |
---|---|---|---|
NFE2L2 | hsa:4780 | path:hsa04141 | Protein processing in endoplasmic reticulum - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05012 | Parkinson disease - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05200 | Pathways in cancer - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05208 | Chemical carcinogenesis - reactive oxygen species - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05225 | Hepatocellular carcinoma - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05417 | Lipid and atherosclerosis - Homo sapiens (human) |
NFE2L2 | hsa:4780 | path:hsa05418 | Fluid shear stress and atherosclerosis - Homo sapiens (human) |
Protein-Protein Interaction(String):
Gene-Drug Network:
Signalink 3.0 modificators
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
AR | NFE2L2 | 20610535 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
ETS1 | NFE2L2 | 18971253 20019798 | trascriptional regulation,stimulation | inferred by curator,chromatin immunoprecipitation assay | TFlink |
GATA1 | NFE2L2 | 19941826 | trascriptional regulation,stimulation | chromatin immunoprecipitation assay | TFlink |
GATA2 | NFE2L2 | 18971253 19941826 | trascriptional regulation,stimulation | inferred by curator,chromatin immunoprecipitation assay | TFlink |
FOXP3 | NFE2L2 | 20554955 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
SMARCA4 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
CEBPA | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
CTCF | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
E2F1 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
E2F4 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
EGR1 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
FOXA1 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
FOXP1 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
FOS | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
HNF4A | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
MITF | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
PRDM14 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
SPI1 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
TRIM28 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
TP53 | NFE2L2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
URS00001E0AEA | NFE2L2 | 23236440 | rna interference,inhibition | miRNA interference luciferase reporter assay | miRSponge |
URS00002E92A8 | NFE2L2 | 23236440 | rna interference,inhibition | miRNA interference luciferase reporter assay | miRSponge |
URS00001B341F | NFE2L2 | 23236440 | rna interference,inhibition | miRNA interference luciferase reporter assay | miRSponge |
URS00002E92A8 | NFE2L2 | 23236440 25416803 27508019 | mrna cleavage,inhibition | western blot,quantitative reverse transcription pcr,miRNA interference luciferase reporter assay | TarBase |
URS00001E0AEA | NFE2L2 | 23236440 25416803 | mrna cleavage,inhibition | miRNA interference luciferase reporter assay | TarBase |
URS00001B341F | NFE2L2 | 22473208 23236440 25226451 25416803 | mrna cleavage,inhibition | experimental interaction detection,western blot,chromatin immunoprecipitation assay,clip,miRNA interference luciferase reporter assay | TarBase |
URS000003ABC4 | NFE2L2 | 19088304 25416803 | mrna cleavage,inhibition | array technology | TarBase |
URS00000600E6 | NFE2L2 | 23622248 25416803 | mrna cleavage,inhibition | clash | TarBase |
URS0000285DCB | NFE2L2 | 22473208 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS0000330617 | NFE2L2 | 22473208 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS0000028BB8 | NFE2L2 | 25416803 27386246 | mrna cleavage,inhibition | experimental interaction detection,quantitative reverse transcription pcr | TarBase |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
GSK3B | NFE2L2 | 22135298 | phosphorylation | N/A | PhosphoSite |
CDK5 | NFE2L2 | 22135298 | phosphorylation | N/A | PhosphoSite |
FYN | NFE2L2 | 22135298 | phosphorylation | N/A | PhosphoSite |
CUL3 | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | CUL3 | 25361965 | interaction type | N/A | PTMCode2 |
MAFK | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | MAFK | 25361965 | interaction type | N/A | PTMCode2 |
JUN | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | JUN | 25361965 | interaction type | N/A | PTMCode2 |
MAFG | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | MAFG | 25361965 | interaction type | N/A | PTMCode2 |
KEAP1 | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | KEAP1 | 25361965 | interaction type | N/A | PTMCode2 |
ATF4 | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | ATF4 | 25361965 | interaction type | N/A | PTMCode2 |
NRF1 | NFE2L2 | 25361965 | interaction type | N/A | PTMCode2 |
NFE2L2 | NRF1 | 25361965 | interaction type | N/A | PTMCode2 |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
MAPK9 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
KPNA3 | NFE2L2 | 21988832 24234451 25348397 | physical association | two hybrid,physical interaction,two hybrid array | ComPPI,IntAct |
RARA | NFE2L2 | 18048326 24234451 25348397 | physical association | anti bait coimmunoprecipitation,anti tag coimmunoprecipitation,physical interaction | ComPPI,IntAct |
CDKN1A | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
ATF4 | NFE2L2 | 11274184 14525934 24234451 25348397 26700459 27898060 | association,physical association | two hybrid,experimental interaction detection,physical interaction,chromatin immunoprecipitation assay,in vitro,in vivo,proximity ligation assay,two hybrid | ComPPI,HPRD,IntAct,OmniPath |
KEAP1 | NFE2L2 | 11439354 14525934 16888629 17015834 18757741 19706542 21988832 24234451 25348397 9887101 | physical association | anti bait coimmunoprecipitation,anti tag coimmunoprecipitation,two hybrid,experimental interaction detection,isothermal titration calorimetry,pull down,x-ray crystallography,physical interaction,in vitro,in vivo | ComPPI,HPRD,IntAct |
UBE2E2 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
UBE2E3 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
PRKCQ | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
SIAH2 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
MAPK8 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
PRKCA | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
PRKCD | NFE2L2 | 12198130 14525934 25348397 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
CASP3 | NFE2L2 | 10510468 14525934 25348397 | N/A | two hybrid,experimental interaction detection,in vitro,in vivo,two hybrid | ComPPI,HPRD |
JUN | NFE2L2 | 12805554 14525934 25348397 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
MAF | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
CREBBP | NFE2L2 | 11683914 14525934 25348397 | N/A | two hybrid,experimental interaction detection,physical interaction,in vitro,in vivo,two hybrid | ComPPI,HPRD |
SUMO1 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
TCF20 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
HDAC3 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
CHD6 | NFE2L2 | 14525934 16314513 25348397 27898060 | N/A | two hybrid,experimental interaction detection,in vivo,two hybrid | ComPPI,HPRD,OmniPath |
JUND | NFE2L2 | 14525934 25348397 9872330 | N/A | experimental interaction detection,in vivo | ComPPI,HPRD |
NFE2L2 | MAFK | 10747902 11013233 14525934 21988832 24234451 25348397 9150357 | physical association | two hybrid,experimental interaction detection,physical interaction,two hybrid array,in vitro,in vivo,two hybrid prey pooling approach | ComPPI,HPRD,IntAct |
NFE2L2 | PPARG | 10930400 14525934 25348397 27898060 | N/A | experimental interaction detection,in vitro | ComPPI,HPRD,OmniPath |
NFE2L2 | MAFG | 11013233 14525934 18692475 21988832 24234451 25348397 25416956 9150357 | physical association | two hybrid,experimental interaction detection,physical interaction,mammalian protein protein interaction trap,two hybrid array,two hybrid pooling approach,two hybrid fragment pooling approach,in vitro,in vivo,two hybrid prey pooling approach | ComPPI,HPRD,IntAct |
NFE2L2 | EIF2AK3 | 14517290 14525934 25348397 | N/A | two hybrid,experimental interaction detection,physical interaction,in vitro,in vivo,two hybrid | ComPPI,HPRD |
NFE2L2 | MAFF | 12490281 14525934 25348397 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
NFE2L2 | PMF1 | 10419538 11256947 12020345 14525934 25348397 27898060 | N/A | two hybrid,experimental interaction detection,physical interaction,in vitro,two hybrid | ComPPI,HPRD,OmniPath |
NFE2L2 | COPS7A | 12020345 14525934 25348397 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
NFE2L2 | CASP1 | 10510468 14525934 25348397 | N/A | two hybrid,experimental interaction detection,in vivo,two hybrid | ComPPI,HPRD |
NFE2L2 | TRIM24 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | SMARCA4 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | CUL3 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | NCOR2 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | NCOR1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | YY1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | MYC | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | BACH1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | PRKCH | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | PRKCG | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | SQSTM1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | GADD45GIP1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | GSK3B | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | PGAM5 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | ENC1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | BPTF | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | SUMO2 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | RNF4 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | NFE2L3 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | CREB3 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | AHR | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | RBMX | 21988832 24234451 25348397 | physical association | two hybrid,physical interaction,two hybrid array | ComPPI,IntAct |
NFE2L2 | NQO1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | BRCA1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | AKT1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | MAP2K1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | MAPK7 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | HDAC1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | HDAC2 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | FBXW11 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | TNNT1 | 24234451 25348397 25416956 | physical association | physical interaction,two hybrid array,two hybrid prey pooling approach,validated two hybrid | ComPPI,IntAct |
NFE2L2 | WAC | 24234451 25348397 25416956 | physical association | physical interaction,two hybrid array,two hybrid prey pooling approach,validated two hybrid | ComPPI,IntAct |
NFE2L2 | UBC | 17420218 17591699 17785452 18512965 19279002 19786557 20173742 20307651 21245377 25348397 27898060 | N/A | anti tag coimmunoprecipitation,covalent binding,physical interaction,comigration in sds page | ComPPI,OmniPath |
NFE2L2 | BTRC | 21245377 22964642 25348397 25900982 26091241 27898060 | N/A | physical interaction | ComPPI,OmniPath |
NFE2L2 | TRIM28 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | RBM45 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | CDH1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | PAQR3 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | PPP1R13L | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | DCAF11 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | NCF1B | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | NCF1 | 25348397 | N/A | physical interaction | ComPPI |
NFE2L2 | UBA52 | 25348397 | N/A | anti tag coimmunoprecipitation,covalent binding,physical interaction,comigration in sds page | ComPPI |
NFE2L2 | EEF1G | 21597468 24234451 25348397 | physical association | anti bait coimmunoprecipitation | ComPPI,IntAct |
NFE2L2 | KDM1A | 24234451 25348397 | physical association | two hybrid,two hybrid array,two hybrid prey pooling approach | ComPPI,IntAct |
UBB | NFE2L2 | 25348397 | N/A | anti tag coimmunoprecipitation,covalent binding,physical interaction,comigration in sds page | ComPPI |
RPS27A | NFE2L2 | 25348397 | N/A | anti tag coimmunoprecipitation,covalent binding,physical interaction,comigration in sds page | ComPPI |
MAP2K2 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
NFE2 | NFE2L2 | 12805554 14525934 25348397 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
NFE2L2 | HYOU1 | 24234451 26700459 | association | chromatin immunoprecipitation assay | IntAct |
NFE2L2 | PML | 24234451 28777872 | physical association | pull down | IntAct |
H2BC9 | NFE2L2 | 24234451 30021884 | physical association | cross-linking study | IntAct |
HNRNPD | NFE2L2 | 24234451 30021884 | physical association | cross-linking study | IntAct |
CDK5 | NFE2L2 | 25909891 27898060 | N/A | N/A | OmniPath |
SRC | NFE2L2 | 18802114 27898060 | N/A | N/A | OmniPath |
PRKCA | NFE2L2 | 12198130 12947090 19920073 27898060 | stimulant | N/A | OmniPath |
PRKCB | NFE2L2 | 12198130 27898060 | stimulant | N/A | OmniPath |
EIF2AK3 | NFE2L2 | 14517290 27898060 | stimulant | N/A | OmniPath |
FYN | NFE2L2 | 16513647 21097520 21690096 27898060 | inhibition | N/A | OmniPath |
PRKCD | NFE2L2 | 12198130 19920073 27898060 | N/A | N/A | OmniPath |
NFE2L2 | ABCC3 | 19345732 27898060 | N/A | N/A | OmniPath |
NFE2L2 | NQO1 | 18241676 18535259 27898060 | stimulant | N/A | OmniPath |
NFE2L2 | PRDX1 | 15289456 27898060 | stimulant | N/A | OmniPath |
NFE2L2 | CXCL8 | 16220540 27898060 | N/A | N/A | OmniPath |
HDAC2 | NFE2L2 | 18241676 27898060 | inhibition | N/A | OmniPath |
JUND | NFE2L2 | 16545679 27898060 9872330 | N/A | N/A | OmniPath |
SIRT1 | NFE2L2 | 20623181 27898060 | inhibition | N/A | OmniPath |
HDAC3 | NFE2L2 | 18241676 27898060 | inhibition | N/A | OmniPath |
ESR1 | NFE2L2 | 20623181 27898060 | inhibition | N/A | OmniPath |
MAPK13 | NFE2L2 | 16951197 27898060 | inhibition | N/A | OmniPath |
AKT1 | NFE2L2 | 19931411 27898060 | N/A | N/A | OmniPath |
PTGS2 | NFE2L2 | 15917255 27898060 | N/A | N/A | OmniPath |
VEGFA | NFE2L2 | 20185790 22033923 27898060 | N/A | N/A | OmniPath |
NFE2L2 | VEGFA | 20185790 22033923 27898060 | N/A | N/A | OmniPath |
MAF | NFE2L2 | 18694732 27898060 | stimulant | N/A | OmniPath |
MAFG | NFE2L2 | 11013233 16189514 18585411 18692475 21988832 22942279 23661758 23737527 24140708 25416956 27898060 9150357 | N/A | N/A | OmniPath |
JUNB | NFE2L2 | 27898060 9872330 | N/A | N/A | OmniPath |
MAPK3 | NFE2L2 | 19931411 27898060 | N/A | N/A | OmniPath |
TRIM28 | NFE2L2 | 21382013 25995248 27898060 | N/A | N/A | OmniPath |
NFE2L2 | OSGIN1 | 18535259 27898060 | stimulant | N/A | OmniPath |
CREBBP | NFE2L2 | 11154691 11683914 18241676 19273602 21196497 27898060 | stimulant | N/A | OmniPath |
MAPK14 | NFE2L2 | 16951197 27898060 | inhibition | N/A | OmniPath |
NFE2L2 | NFKBIA | 16246346 27898060 | N/A | N/A | OmniPath |
NFE2L2 | HMOX1 | 18241676 18535259 27898060 | stimulant | N/A | OmniPath |
BACH1 | NFE2L2 | 15734732 19897490 27898060 | inhibition | N/A | OmniPath |
SMARCA4 | NFE2L2 | 16923960 27898060 | N/A | N/A | OmniPath |
HDAC1 | NFE2L2 | 18241676 27898060 | inhibition | N/A | OmniPath |
TNF | NFE2L2 | 18202225 27898060 | stimulant | N/A | OmniPath |
KLF2 | NFE2L2 | 18467642 27898060 | stimulant | N/A | OmniPath |
MAP2K6 | NFE2L2 | 16951197 27898060 | inhibition | N/A | OmniPath |
BRCA1 | NFE2L2 | 15520196 27898060 | N/A | N/A | OmniPath |
EP300 | NFE2L2 | 19273602 27898060 | N/A | N/A | OmniPath |
MAPK1 | NFE2L2 | 12198130 16308312 27898060 | N/A | N/A | OmniPath |
CSNK2A1 | NFE2L2 | 17512459 27898060 | inhibition | N/A | OmniPath |
NFE2L2 | GCLM | 16485034 18535259 19808663 27898060 | stimulant | N/A | OmniPath |
KEAP1 | NFE2L2 | 11439354 11909699 12145307 14517290 14585973 15143058 15475350 15572695 15601839 15985429 16006525 16507366 16581765 16785233 16790436 16888629 17020408 17420218 17462537 17591699 17785452 17822677 17903176 18358244 18387606 18417180 18512965 18694732 18757741 18981988 19279002 19560419 19920073 20027226 20173742 20421418 20463144 20484052 20486933 20599909 21262351 21383067 21988832 22215675 22245129 22448038 22558124 22688683 23066931 23382044 23645672 23722832 23857982 23986495 24011591 24130096 24322982 24366543 24512214 24704364 24997453 25582950 25628777 26536456 27898060 9887101 | inhibition | N/A | OmniPath |
NFE2L2 | YY1 | 20309604 27898060 | N/A | N/A | OmniPath |
NFE2L2 | SQSTM1 | 20452972 27898060 | N/A | N/A | OmniPath |
MAPK11 | NFE2L2 | 16951197 27898060 | inhibition | N/A | OmniPath |
GSK3B | NFE2L2 | 16551619 22751928 27898060 | inhibition | N/A | OmniPath |
RBX1 | NFE2L2 | 15572695 27898060 | inhibition | N/A | OmniPath |
MAPK8 | NFE2L2 | 16308312 27898060 | N/A | N/A | OmniPath |
NFE2L2 | CCL2 | 16246346 27898060 | inhibition | N/A | OmniPath |
BTG2 | NFE2L2 | 22493435 27898060 | stimulant | N/A | OmniPath |
IKBKB | NFE2L2 | 18241676 27898060 | inhibition | N/A | OmniPath |
JUN | NFE2L2 | 12805554 19666106 20232342 27898060 9872330 | N/A | N/A | OmniPath |
CUL3 | NFE2L2 | 15367669 15601839 17015834 27898060 | N/A | N/A | OmniPath |
NFKBIE | NFE2L2 | 18241676 27898060 | inhibition | N/A | OmniPath |
MAPK12 | NFE2L2 | 16951197 27898060 | inhibition | N/A | OmniPath |
PTMA | NFE2L2 | 15657435 27898060 | N/A | N/A | OmniPath |
NFE2L2 | CFTR | 20309604 27898060 | inhibition | N/A | OmniPath |
PAG1 | NFE2L2 | 11683914 27898060 | N/A | N/A | OmniPath |
NFE2L2 | ABCC2 | 18038766 27898060 | N/A | N/A | OmniPath |
PIK3CG | NFE2L2 | 19272177 27898060 | N/A | N/A | OmniPath |
GADD45GIP1 | NFE2L2 | 20427290 27898060 | inhibition | N/A | OmniPath |
NFE2L2 | VAMP1 | 16246346 27898060 | inhibition | N/A | OmniPath |
NFE2L2 | UGT2B7 | 18622263 27898060 | N/A | N/A | OmniPath |
MAFF | NFE2L2 | 12490281 23661758 23737527 26186194 27898060 | N/A | N/A | OmniPath |
MT3 | NFE2L2 | 18554677 27898060 | stimulant | N/A | OmniPath |
NFE2L2 | MUC5AC | 20216230 27898060 | inhibition | N/A | OmniPath |
ENC1 | NFE2L2 | 17875699 18981988 19424503 20511222 27898060 | inhibition | N/A | OmniPath |
NOX1 | NFE2L2 | 18802114 20347035 27898060 | N/A | N/A | OmniPath |
PGAM5 | NFE2L2 | 18387606 27898060 | inhibition,stimulant | N/A | OmniPath |
EPX | NFE2L2 | 20229611 27898060 | N/A | N/A | OmniPath |
NFE2L2 | CBR3 | 20806931 27898060 | N/A | N/A | OmniPath |